PCRF Grants

Funding For a Brighter Future

Pediatric Cancer Research Foundation Grants

 Grant Cycle is closed for 2022 submissions for 2023 funding.
A Letter of Intent is required in order to be invited to submit a grant application. Please refer to specific guidelines which can be found under Funding Process.

Grant Information & Procedures

At PCRF, we are unique in our approach to funding childhood cancer research — working directly with doctors, researchers, and nurses to identify the specific challenges they face in bringing new treatments to and caring for children with cancer. Our careful distribution of grants has allowed doctors and nurses to speed up the process of bringing the latest and most promising life-saving treatments to seriously ill children. The result is bringing hope to childhood cancer patients now and in the future.

  • PCRF is an equal opportunity organization.
  • No one is excluded from employment, membership on our governing body, or research support because of race, religion, sex, national origin, age or physical handicap.
  • No infrastructure or support services will be funded.

The Pediatric Cancer Research Foundation awards four types of grants:

  • Emerging Investigator
  • Translational Research Grants
  • Basic Science Grants 
  • Designated Grant Programs
To learn more about some of the scientists we support please click on the boxes below.  

Research Partners

Grant Levels

Pediatric Cancer Research Foundation Awards Four Types of Grants

PCRF awards grants annually to extraordinary researchers offering the best hope for a cure to childhood cancer. Find out more about the variety of grants available and how they help give hope to children and families.

Basic Research Science Grant

This type of grant primarily funds basic science, translational and/or clinical state of the art pediatric cancer research initiatives. This grant level can be awarded over multiple years and up to $150,000/year. These type of grants fund work that is the basis for childhood cancer research, helping to move science in the direction of improved treatments and eventually finding a cure. 

Translational Research Grant

This type of grant primarily funds new research protocols and therapies that hold promise for improved outcomes and accelerates cures from the laboratory bench to the bedside of children and teens with high-risk cancers. This Grant is given to programs that involve open, multi-institutional cancer clinical trials or consortia, and implement new approaches to therapy. This award may provide up to $75,000 per year for multiple years.

Emerging Investigator Fellowship Grant

These grants are designed to support Post-Doctoral Fellowships and Clinical Investigator training for emerging pediatric cancer researchers to pursue exciting research ideas. Applicants must have completed two years of their fellowship, or not more than two years as a junior faculty instructor or assistant professor at the start of the award period. These grants encourage and cultivate the best and brightest researchers of the future. Awards will provide up to a maximum of $50,000 per year and can be renewed annually.

Designated Grant Program

These grants fund projects in communities or regions local to the specific donor or fundraising activity. Outside contributing organizations, fundraisers and donors work with the Foundation to identify a specific project, focus on a specific disease type, facility or awareness program. Grants can be for any specific amount as designated by the donor or contributing organization.

Grant Process and Criteria

The Pediatric Cancer Research Foundation follows a carefully planned grant procedure in order to identify and fund the most promising next-generation treatments.

A carefully planned grant procedure guides the process that ensures the most promising research grants get funded by the Pediatric Cancer Research Foundation. All applicants are required to submit a Letter of Intent. This process will open January 1st through March 1st. Refer to the PCRF Letters of Intent (LOI)  guidelines for specific details. The PCRF Scientific Advisory Board will review and approve Letters of Intent. Upon approval of the LOI, applicants will be notified in mid-March whether or not they are invited to submit a grant application through proposalCENTRAL. Completed applications must be electronically submitted through proposalCENTRAL by no later than 5:00pm PST on June 1st. Any application submitted after the June 1st deadline will not be considered. There will be no extensions granted to this deadline.. 

Scientific peer review is conducted by PCRF’s External  Review Committee according to the review criteria summarized below. The Scientific Review Committee will direct their recommendation for awards based on scientific merit to the PCRF Scientific Affairs Committee. The PCRF Board of Directors will consider the recommendations of the Scientific Affairs Committee and will determine the number and dollar amount of awards to be funded based on the budget approved for the year. 

The External Review Committee will review applications during the months of June through August. Applications will be judged on the Review Criteria (see below). If any application does not meet the goals of PCRF it will be disqualified. Applicants selected for funding will be notified during the period November 1st through December 31. Funding status is relayed by email only and not available by telephone. All priority scores are considered confidential and are available to the External Review Committee, Scientific Affairs Committee, PCRF Board of Directors, and administrative staff only. Written critiques of applications are not provided to applicants. 

  • January 1st
    • Cycle opens for Letter of Intent submission
  • March 1st
    • Letter of Intent – deadline
  • March 15th
    • Applicants are invited to submit grant application
  • June 1st
    • Grant application – deadline 5 p.m. PST
  • Early June
    • Applications sent to outside review
  • August 2nd
    • Outside reviewer – deadline
  • September
    • Scientific Advisory Committee meeting
  • October
    • PCRF Board Meeting
  • November
    • Selected applicants contacted
  • December
    • Letter of agreement signed
  • January 1st
    • Grant start date

Grant Criteria

  • The probability of an advance in prevention, diagnosis or treatment for the near-term
  • The novelty of the concept and strategy
  • The clarity of presentation
  • The overall plan for bringing the research findings to clinical application
  • Experience, background, and qualifications of the investigators
  • Adequacy of resources and environment (Facilities, patients, etc.)

Grant Funding Details

Funds awarded shall be used solely for the purposes specified in the application submitted for consideration and in strict compliance with the budget submitted with the application. No indirect costs will be funded.

PCRF uses the calendar year of accounting, and thus, all awards will be activated on January 1 of the year following the application, and a contract will be forwarded for signature by the grantee and sponsoring institution. Grant payments will be made periodically (generally quarterly or semiannually) at the discretion of PCRF and subsequent payments will only be remitted upon submission, review, and approval of the appropriate Progress and Accounting Reports as discussed below. Payments will be made to the controller or other fiscal officer for the institution as indicated in the application’s budget. The institution will be responsible for disbursing the funds to the grantee in accordance with the budget submitted.

PCRF is not responsible if for any reason funds are expended at an amount in excess of the awarded Grant amount. It will be the responsibility of the sponsoring institution to make restitution to PCRF for any remaining funds in the event of transfer or premature termination of the grant.

If a Primary Investigator grantee transfers or terminates from his sponsoring institution during the course of the Grant award period, the Grant will immediately terminate, and can be only be transferred to another institution with the written approval of PCRF’s Scientific Committee and Board of Directors.

Failure of the grantee and/or sponsoring institution to adhere to any of the terms and conditions in the contract shall constitute sufficient grounds for PCRF, in its discretion, to withhold any or all funds due until the deficiency is corrected. Either PCRF or the sponsoring institution may then terminate the contract upon giving ninety (90) days written notice, if the deficiency cannot be corrected. In such case, any unexpended balance of funds must be returned to PCRF.

PCRF grants do not constitute an employer-employee relationship between the recipient and PCRF.

PCRF does not assume any legal responsibility or obligation for the conduct or acts of the recipient.

Sale or Transfer of Technology

  • Recognition and Credits
  • Transfers
  • Scientific Reports
  • Forms and Grant Manual
  • Accounting Reports
  • Deadlines
  • Confidentiality

Applications & Questions

Our Grant Levels, Grant Procedures, and Funding Process is available here on this website. Contact us for questions relating to the granting process.

Pediatric Cancer Research Foundation
2151 Michelson Dr., Suite 180,
Irvine, CA 92612

Telephone:(949) 859-6312
Fax (949) 859-6323

Change a Life Today

Some people say that children make up 10% of our cancer population, but they are 100% of our future! ~ Dr. Alex Huang, Case Western